These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A Novel Truncated CHAP Modular Endolysin, CHAPSAP26-161, That Lyses Staphylococcus aureus, Acinetobacter baumannii, and Clostridioides difficile, and Exhibits Therapeutic Effects in a Mouse Model of A. baumannii Infection. Choi YJ, Kim S, Dahal RH, Kim J. J Microbiol Biotechnol; 2024 Aug 28; 34(8):1718-1726. PubMed ID: 39081246 [Abstract] [Full Text] [Related]
10. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity. Yuan Y, Li X, Wang L, Li G, Cong C, Li R, Cui H, Murtaza B, Xu Y. Microb Biotechnol; 2021 Mar 28; 14(2):403-418. PubMed ID: 32519416 [Abstract] [Full Text] [Related]
12. Characterization of endolysin from a Salmonella Typhimurium-infecting bacteriophage SPN1S. Lim JA, Shin H, Kang DH, Ryu S. Res Microbiol; 2012 Apr 28; 163(3):233-41. PubMed ID: 22289622 [Abstract] [Full Text] [Related]
13. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity. Kim S, Jin JS, Choi YJ, Kim J. Viruses; 2020 Nov 23; 12(11):. PubMed ID: 33238548 [Abstract] [Full Text] [Related]
14. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus. Haddad Kashani H, Fahimi H, Dasteh Goli Y, Moniri R. Front Cell Infect Microbiol; 2017 Nov 23; 7():290. PubMed ID: 28713777 [Abstract] [Full Text] [Related]
16. Cajanol inhibits the growth of Escherichia coli and Staphylococcus aureus by acting on membrane and DNA damage. Liu XL, Zhang XJ, Fu YJ, Zu YG, Wu N, Liang L, Efferth T. Planta Med; 2011 Jan 23; 77(2):158-63. PubMed ID: 20803417 [Abstract] [Full Text] [Related]
17. Inhibition of RND-type efflux pumps confers the FtsZ-directed prodrug TXY436 with activity against Gram-negative bacteria. Kaul M, Zhang Y, Parhi AK, Lavoie EJ, Pilch DS. Biochem Pharmacol; 2014 Jun 01; 89(3):321-8. PubMed ID: 24637241 [Abstract] [Full Text] [Related]
18. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria. Sui B, Wang X, Zhao T, Zhen J, Ren H, Liu W, Zhang X, Zhang C. Appl Environ Microbiol; 2023 Jul 26; 89(7):e0058123. PubMed ID: 37338346 [Abstract] [Full Text] [Related]
19. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria. Zhang S, Chang Y, Zhang Q, Yuan Y, Qi Q, Lu X. Microb Cell Fact; 2022 Aug 23; 21(1):171. PubMed ID: 35999567 [Abstract] [Full Text] [Related]